Atlas Trials

Oral Gemifloxacin Versus Intravenous Cefotaxime in Treatment of Spontaneous Bacterial Peritonitis

Clinical trial NCT04168099 · RECRUITING

Trial details

NCT number
NCT04168099
Sponsor
Tanta University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Spontaneous Bacterial Peritonitis
Start date
2018-12-01
Primary completion
2028-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.